For non-injured adults seeking attention, processing-speed, or executive-function gains. The 2020 Hadanny RCT in healthy >64-year-olds showed significant cognitive enhancement with HBOT compared to control, alongside cerebral blood flow increases on perfusion MRI. The 2022 Marcinkowska systematic review across 42 studies found broadly consistent cognitive signals.
Hyperbaric oxygen’s relationship to cognition spans two distinct questions: whether it aids recovery after injury, and whether it can improve cognition in otherwise healthy people. In a randomized controlled trial of healthy adults over 64, Hadanny and colleagues (2020) reported improved global cognitive function and changes in cerebral blood flow after a three-month protocol. Mechanistic and preclinical work — including a 2018 Alzheimer’s mouse-model study showing reduced neuroinflammation — offers biological plausibility, though animal results do not translate directly to humans. The honest summary: the healthy-aging cognition signal is promising but rests largely on single-center trials that need independent replication, and “cognitive enhancement” should be treated as preliminary rather than established.
Supporting research in our library
- Hadanny 2020 — RCT of cognition in healthy older adults.
- Shapira 2018 — preclinical Alzheimer’s mouse model.
- Rossignol 2009 — controlled trial in children with autism.
Related conditions & guides
Explore HBOT & longevity, HBOT for stroke recovery, and our guide to understanding ATA pressure.
Authoritative reference
For external context, see the primary study on PubMed.
This content is for educational purposes only and is not medical advice. Hyperbaric oxygen therapy carries genuine clinical risks and differs by pressure; consult a qualified clinician. Read our full medical disclaimer.